Hindustan Bio Sciences Limited intimates exchange of board meeting scheduled for May 30, 2026.
Board to consider audited financial results for Q4 and FY ending March 31, 2026.
Meeting will also review annual audit report and other matters with chair's permission.
Disclosure made under SEBI Listing Regulations Regulation 29(1)(a) compliance requirements.